Discovery Life Sciences, a biospecimen and biomarker specialists, completed the acquisition of AllCells, a provider of primary cell products. Financial terms were not disclosed. "We are very excited to welcome the AllCells team to the Discovery family. Bringing these two great companies together creates a scalable, end-to-end solution that gives our clients unprecedented access to reliable human cellular starting materials with integrated multi-omic analytic services to support cell and gene therapies," Glenn Bilawsky, Discovery CEO.